In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

DeCode genetics bought by consortium of private investors

Executive Summary

After filing for bankruptcy at the end of 2009, deCode genetics (DNA tests and personal genome scans) has sold its deCode genetics EHF subsidiary and its drug discovery programs to Saga Investments (a consortium that includes original investors Polaris Ventures and ARCH Venture Partners), which is rescuing the debt-heavy company. DeCode genetics Inc. changed its name to DGI Resolution Inc., which will liquidate.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Buy-out
    • Payment Includes Cash
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register